PatentsChina
China’s National Medical Products Administration Launches Public Test for Drug Patent Linkage Registration Platform
On May 18, 2021, China’s Center for Drug Evaluation (CDE) under the National Medical Products Administration (NMPA) announced the public testing phase of its patent linkage registration platform. This system, designed to facilitate early settlement of drug patent disputes, is open for testing through May 31, 2021. The…
Thursday, May 20, 2021